Wearable Sensors and Smartphone for Stroke
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn if wearable sensor data visualization on smartphones can improve the use of the stroke-affected limb during everyday activities. Chronic stroke survivors (\>12 months from onset) ages 18-80 years old with residual upper extremity motor impairments may be eligible to participate. The main question it aims to answer is: Does the mobile health (mHealth) intervention help to improve the use of the stroke-affected upper-limb during daily living? The study is designed so each participant serves as their own control. Researchers will compare information from the baseline, intervention, and retention time periods to see if visualizing the data on the smartphone impacts the participant's daily use of the arm. Participants will be asked to wear a set of wearable ring and wrist sensors and interact with a custom-designed smartphone app, aiming to increase the use of their stroke-affected limb during daily activities as much as possible. They will receive feedback from the app, communicate with study therapists, participate in goal setting, complete clinical assessments, and share about their experience using the system during a virtual interview.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, significant changes in your medication plan during the study that might affect arm use are not allowed.
What data supports the effectiveness of the treatment mHealth using wearable sensors and smartphones for stroke?
Research shows that wearable sensors and smartphone technology can help monitor and assess stroke patients' movements, providing valuable information for personalized rehabilitation. This approach can be cost-effective and accessible, offering a promising alternative to traditional rehabilitation methods.12345
Is it safe to use wearable sensors and smartphone apps for stroke monitoring and prevention?
Research shows that wearable devices and smartphone apps are generally safe for monitoring heart conditions like atrial fibrillation and managing stroke risk factors. They help in early detection and management of conditions, and patients find them useful and are open to using them alongside regular medical care.46789
How does the mHealth treatment using wearable sensors and smartphones differ from other stroke treatments?
The mHealth treatment for stroke is unique because it uses wearable sensors and smartphones to monitor and assess patients both in clinical settings and at home, allowing for personalized rehabilitation. This approach provides real-time feedback and detailed evaluation of motor impairments, which can help tailor therapy to individual needs, unlike traditional methods that may not offer such continuous and comprehensive monitoring.310111213
Research Team
Paolo Bonato, PhD
Principal Investigator
Director of Motion Analysis Laboratory
Eligibility Criteria
This trial is for chronic stroke survivors aged 18-80 with upper limb motor impairments who are more than 12 months post-stroke onset. Participants should be able to use a smartphone and wear sensors on their affected limb.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants wear wrist and index finger-worn sensors bilaterally for 14 days and self-annotate activities
Intervention
Participants interact with the Intervention app, receive feedback, and engage in Zoom calls with therapists
Retention
Participants continue wearing sensors without app feedback or clinician interactions to assess withdrawal effects
Follow-up
Participants are monitored for safety and effectiveness after the retention phase
Treatment Details
Interventions
- mHealth
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spaulding Rehabilitation Hospital
Lead Sponsor
University of Massachusetts, Amherst
Collaborator
University of Maryland, College Park
Collaborator
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator